Infinity Pharma

Investors that purchased the Company’s securities and have suffered a loss, please fill in transaction information below, or email to info@portnoylaw.com.

Are you a current or former employee of the company?*YesNo

Purchases

+Additional Purchases

Sales

+Additional Sales

If you prefer, you may submit your transaction information or comments/questions in the box below:




There is no cost or obligation associated with submitting your information. If you are a shareholder who suffered a loss, please submit your contact information and purchase information to participate in the putative class action.

We also encourage you to contact Lesley F. Portnoy of The Portnoy Law Firm, at 310.692.8883, to discuss your rights free of charge. You can also reach us through the firm’s website at www.portnoylaw.com, or by email at info@portnoylaw.com.

If you choose to take no action, you can remain an absent class member.

Joining the case through the Portnoy Law website enables investors to learn about their legal claims and take an active role in recovering their losses.

The Portnoy Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

CONTACT:
Portnoy Law Firm
Lesley F. Portnoy, Esq.,
www.portnoylaw.com
Office: 310.692.8883
1800 Century Park East, Suite 600
Los Angeles, CA 90067
info@portnoylaw.com

The class action complaint states that during the designated Class Period, the Defendants were alleged to have engaged in deceptive practices by making false or misleading statements. They were also accused of failing to disclose important negative information about the Company’s business, operations, and future prospects. Specifically, the Defendants were said to have not accurately communicated that Infinity had exaggerated its potential for success with a breast cancer treatment and had an excessively optimistic view of its breast cancer studies. These omissions and inaccuracies were expected to have a detrimental impact on Infinity’s business, financial performance, and reputation once they became known. As a result, the positive statements the Defendants had made about the Company’s business, operations, and prospects were alleged to be significantly misleading and without reasonable grounds throughout the relevant period.